Viva Biotech

IPO

Structure-based drug discovery services

Public · Shanghai, China · Founded 2007 · $225.0M raised

Headquarters
Shanghai
Employees
1001–5000
Founded
2007
Business Model
B2B
Total Funding
$225.0M
Last Round
$15.0M Corporate RoundJan 2024
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.

About

Viva Biotech Holdings (HKEX: 1873) is a leading drug discovery services company that provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company uses specialized laboratory tools including structure-based drug design, protein science, compound screening, and binding target analysis to guide early-stage drug development for its clients. Listed on the Hong Kong Stock Exchange in May 2019, Viva Biotech has served hundreds of biotech and pharmaceutical customers globally and acts as a contract research organization (CRO) and research partner rather than an independent drug developer.

Summary

Viva Biotech is a Biotech company based in Shanghai, China, founded in 2007. It has raised $225.0M in total across 3 rounds, most recently a $15.0M Corporate Round in Jan 2024. Investors include Viva Ventures Biotech Fund, Temasek and HighLight Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Corporate RoundCorporate Round2024 (est.)
$15.0M

Sign up to see all 4 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Viva Biotech on Indexed.vc
<a href="https://indexed.vc/companies/viva-biotech"><img src="https://indexed.vc/api/badge/company/viva-biotech" alt="Viva Biotech on Indexed.vc" width="260" height="76" /></a>